BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 25264100)

  • 1. Direct evidence for the atovaquone action on the Plasmodium cytochrome bc1 complex.
    Siregar JE; Kurisu G; Kobayashi T; Matsuzaki M; Sakamoto K; Mi-ichi F; Watanabe Y; Hirai M; Matsuoka H; Syafruddin D; Marzuki S; Kita K
    Parasitol Int; 2015 Jun; 64(3):295-300. PubMed ID: 25264100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation underlying resistance of Plasmodium berghei to atovaquone in the quinone binding domain 2 (Qo(2)) of the cytochrome b gene.
    Siregar JE; Syafruddin D; Matsuoka H; Kita K; Marzuki S
    Parasitol Int; 2008 Jun; 57(2):229-32. PubMed ID: 18248769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical atovaquone-proguanil resistance of Plasmodium falciparum associated with cytochrome b codon 268 mutations.
    Musset L; Bouchaud O; Matheron S; Massias L; Le Bras J
    Microbes Infect; 2006 Sep; 8(11):2599-604. PubMed ID: 16962361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytochrome b mutation Y268S conferring atovaquone resistance phenotype in malaria parasite results in reduced parasite bc1 catalytic turnover and protein expression.
    Fisher N; Abd Majid R; Antoine T; Al-Helal M; Warman AJ; Johnson DJ; Lawrenson AS; Ranson H; O'Neill PM; Ward SA; Biagini GA
    J Biol Chem; 2012 Mar; 287(13):9731-9741. PubMed ID: 22282497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Within-Host Selection of Drug Resistance in a Mouse Model of Repeated Incomplete Malaria Treatment: Comparison between Atovaquone and Pyrimethamine.
    Nuralitha S; Siregar JE; Syafruddin D; Roelands J; Verhoef J; Hoepelman AI; Marzuki S
    Antimicrob Agents Chemother; 2016 Jan; 60(1):258-63. PubMed ID: 26503662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular epidemiology of malaria in Cameroon. XVII. Baseline monitoring of atovaquone-resistant Plasmodium falciparum by in vitro drug assays and cytochrome b gene sequence analysis.
    Basco LK
    Am J Trop Med Hyg; 2003 Aug; 69(2):179-83. PubMed ID: 14506774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome b mutations that modify the ubiquinol-binding pocket of the cytochrome bc1 complex and confer anti-malarial drug resistance in Saccharomyces cerevisiae.
    Kessl JJ; Ha KH; Merritt AK; Lange BB; Hill P; Meunier B; Meshnick SR; Trumpower BL
    J Biol Chem; 2005 Apr; 280(17):17142-8. PubMed ID: 15718226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Menoctone Resistance in Malaria Parasites Is Conferred by M133I Mutations in Cytochrome
    Blake LD; Johnson ME; Siegel SV; McQueen A; Iyamu ID; Shaikh AK; Shultis MW; Manetsch R; Kyle DE
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmodium chabaudi chabaudi malaria parasites can develop stable resistance to atovaquone with a mutation in the cytochrome b gene.
    Afonso A; Neto Z; Castro H; Lopes D; Alves AC; Tomás AM; Rosário VD
    Malar J; 2010 May; 9():135. PubMed ID: 20492669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural analysis of atovaquone-inhibited cytochrome bc1 complex reveals the molecular basis of antimalarial drug action.
    Birth D; Kao WC; Hunte C
    Nat Commun; 2014 Jun; 5():4029. PubMed ID: 24893593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the mechanism of atovaquone drug resistance in Plasmodium falciparum cytochrome b mutation Y268S using computational methods.
    Akhoon BA; Singh KP; Varshney M; Gupta SK; Shukla Y; Gupta SK
    PLoS One; 2014; 9(10):e110041. PubMed ID: 25334024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular surveillance of mutations in the cytochrome b gene of Plasmodium falciparum in Gabon and Ethiopia.
    Gebru T; Hailu A; Kremsner PG; Kun JF; Grobusch MP
    Malar J; 2006 Nov; 5():112. PubMed ID: 17118179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Confirmation of emergence of mutations associated with atovaquone-proguanil resistance in unexposed Plasmodium falciparum isolates from Africa.
    Happi CT; Gbotosho GO; Folarin OA; Milner D; Sarr O; Sowunmi A; Kyle DE; Milhous WK; Wirth DF; Oduola AM
    Malar J; 2006 Oct; 5():82. PubMed ID: 17020611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decoding the Molecular Effects of Atovaquone Linked Resistant Mutations on
    Chebon-Bore L; Sanyanga TA; Manyumwa CV; Khairallah A; Tastan Bishop Ö
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in the cytochrome b gene of Plasmodium berghei conferring resistance to atovaquone.
    Syafruddin D; Siregar JE; Marzuki S
    Mol Biochem Parasitol; 1999 Nov; 104(2):185-94. PubMed ID: 10593174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Saccharomyces cerevisiae-based mutational analysis of the bc1 complex Qo site residue 279 to study the trade-off between atovaquone resistance and function.
    Song Z; Clain J; Iorga BI; Yi Z; Fisher N; Meunier B
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4053-8. PubMed ID: 25918152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization of the cytochrome b gene and in vitro atovaquone susceptibility of Plasmodium falciparum isolates from Kenya.
    Ingasia LA; Akala HM; Imbuga MO; Opot BH; Eyase FL; Johnson JD; Bulimo WD; Kamau E
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1818-21. PubMed ID: 25583715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Within-Host Selection of Drug Resistance in a Mouse Model Reveals Dose-Dependent Selection of Atovaquone Resistance Mutations.
    Nuralitha S; Murdiyarso LS; Siregar JE; Syafruddin D; Roelands J; Verhoef J; Hoepelman AIM; Marzuki S
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28193656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different mutation patterns of atovaquone resistance to Plasmodium falciparum in vitro and in vivo: rapid detection of codon 268 polymorphisms in the cytochrome b as potential in vivo resistance marker.
    Schwöbel B; Alifrangis M; Salanti A; Jelinek T
    Malar J; 2003 Mar; 2():5. PubMed ID: 12665429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apparent absence of atovaquone/proguanil resistance in 477 Plasmodium falciparum isolates from untreated French travellers.
    Musset L; Pradines B; Parzy D; Durand R; Bigot P; Le Bras J
    J Antimicrob Chemother; 2006 Jan; 57(1):110-5. PubMed ID: 16319183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.